Journal article
Impaired vascular redox signalling in the vascular complications of obesity and diabetes mellitus
- Abstract:
- Significance: Oxidative stress, a crucial regulator of vascular disease pathogenesis, may be involved in the vascular complications of obesity, systemic insulin resistance and diabetes mellitus. Recent advances: Excessive production of reactive oxygen species in the vascular wall has been linked with vascular disease pathogenesis. Recent evidence has revealed that vascular redox state is dysregulated in cases of obesity, systemic insulin resistance and diabetes mellitus, potentially participating to the well-known vascular complications of these disease entities. Critical issues: The detrimental effects of obesity and the metabolic syndrome on vascular biology have been extensively described at a clinical level. Furthermore, vascular oxidative stress has often been associated with the presence of obesity and insulin resistance as well as a variety of detrimental vascular phenotypes. However, the mechanisms of vascular redox state regulation under conditions of obesity and systemic insulin resistance, as well as their clinical relevance, are not adequately explored. In addition, the notion of vascular insulin resistance, and its relationship with systemic parameters of obesity and systemic insulin resistance, is not fully understood. In this review, we present all the important components of vascular redox state and the evidence linking oxidative stress with obesity and insulin resistance. Future directions: Future studies are required to describe the cellular effects and the translational potential of vascular redox state in the context of vascular disease. In addition, further elucidation of the direct vascular effects of obesity and insulin resistance is required for better management of the vascular complications of diabetes mellitus.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 527.0KB, Terms of use)
-
- Publisher copy:
- 10.1089/ars.2017.7421
Authors
+ NovoNordisk Foundation
More from this funder
- Funding agency for:
- Antoniades, C
- Grant:
- NNF15CC0018486
+ National Institute for Health Research
More from this funder
- Funding agency for:
- Antoniades, C
- Grant:
- NNF15CC0018486
+ British Heart Foundation
More from this funder
- Funding agency for:
- Antoniades, C
- Grant:
- NNF15CC0018486
+ Alexandros S. Onassis Public Benefit
Foundation
More from this funder
- Funding agency for:
- Akoumianakis, I
- Publisher:
- Mary Ann Liebert
- Journal:
- Antioxidants and Redox Signaling More from this journal
- Volume:
- 30
- Issue:
- 3
- Pages:
- 333-353
- Publication date:
- 2017-10-30
- Acceptance date:
- 2017-10-23
- DOI:
- EISSN:
-
1557-7716
- ISSN:
-
1523-0864
- Pmid:
-
29084432
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:742474
- UUID:
-
uuid:53565d0c-baf6-408b-8bbe-a0aa788c7d03
- Local pid:
-
pubs:742474
- Source identifiers:
-
742474
- Deposit date:
-
2017-11-07
Terms of use
- Copyright holder:
- Mary Ann Liebert, Inc
- Copyright date:
- 2017
- Notes:
- Copyright © Mary Ann Liebert, Inc. This is the accepted manuscript version of the article. The final version is available online from Mary Ann Liebert at: https://doi.org/10.1089/ars.2017.7421
If you are the owner of this record, you can report an update to it here: Report update to this record